R&G PharmaStudies Co., Ltd.

SZSE:301333 Stock Report

Market Cap: CN¥3.9b

R&G PharmaStudies Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

David Wu

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureless than a year

Recent management updates

Recent updates

R&G PharmaStudies' (SZSE:301333) Dividend Will Be Reduced To CN¥0.20

Jul 01
R&G PharmaStudies' (SZSE:301333) Dividend Will Be Reduced To CN¥0.20

Is There An Opportunity With R&G PharmaStudies Co., Ltd.'s (SZSE:301333) 27% Undervaluation?

Jun 06
Is There An Opportunity With R&G PharmaStudies Co., Ltd.'s (SZSE:301333) 27% Undervaluation?

Shareholders Will Be Pleased With The Quality of R&G PharmaStudies' (SZSE:301333) Earnings

Apr 29
Shareholders Will Be Pleased With The Quality of R&G PharmaStudies' (SZSE:301333) Earnings

CEO

David Wu (63 yo)

no data

Tenure

Mr. Wu Jie, also known as David, MBA serves as Chairman and General manager of R&G PharmaStudies Co., Ltd. He served as General Manager and Director of Tianfa Petroleum Co., Ltd.


Board Members

NamePositionTenureCompensationOwnership
Wei Wang
Deputy GM & Directorno dataCN¥822.90kno data
Jie Wu
Chairman & GMno datano datano data
Leyan Teng
COO, Senior VP & Directorno datano data0.75%
CN¥ 29.4m
Shuqi Li
Senior VPno datano datano data
Feng Li
Independent Directorless than a yearno datano data
Hongbei Zheng
Directorno datano data12.23%
CN¥ 479.8m
Weiguo Zhang
Supervisorno datano data0.072%
CN¥ 2.8m
Hong Guan
Supervisory Board Chairmanno datano data0.12%
CN¥ 4.7m
Yan Zheng
Supervisorno datano data0.027%
CN¥ 1.1m
Qiang Chen
Directorno datano datano data
Wen Sun
Independent Directorless than a yearno datano data
Haohai Shi
Independent Directorless than a yearno datano data

0.3yrs

Average Tenure

55yo

Average Age

Experienced Board: 301333's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.